Culmination Bio focuses on enhancing healthcare through the development of innovative clinical insights, therapeutic targets, and diagnostic opportunities. Central to their approach is the Culmination Intelligence Platform, which integrates diverse, multi-dimensional, longitudinal clinical data alongside matched biospecimens. This platform serves as a powerful insight engine, leveraging vast de-identified patient datasets to improve the understanding of diagnostics and therapeutics. By utilizing linked genomic, biological, health, and claims data, Culmination aims to generate novel insights that can lead to better health outcomes.

A key feature of the Culmination Intelligence Platform is its capacity for omics-level data generation, which includes whole genome sequencing (WGS), whole transcriptome sequencing (WTS), whole exome sequencing (WES), and proteomics. The platform's extensive collection of millions of linked biospecimens allows for just-in-time omics analyses, facilitating a deeper understanding of health data and medical research. Through these advanced technologies, Culmination Bio is positioned to become a trusted source for healthcare insights, ultimately striving to improve lives through their discoveries and partnerships with leading technology and biopharmaceutical companies.

United States

Culmination is changing the world by discovering better health.  We provide unparalleled value to health care organizations by unlocking biological data and enriching it with clinical, claims, and genomic data. We are on a journey to radically improve everyone's future health care experience. Culmination Bio will become the trusted source for health care insights and for generating discoveries that improve people’s lives.

Culmination Bio

Company Details